Abstract
Patients with esophageal squamous cell carcinoma (ESCC) have a poor prognosis. However, the related mechanisms are unclear, thus we investigated the expression of HO-1 in ESCC tissue and explored possible mechanisms of tumor progression. Expression of HO-1 was examined by immunohistochemistry in 143 ESCC tumors. The correlation of HO-1 with clinicopathological characteristics was also examined. Two human ESCC cell lines, TE-13 and Eca109 were studied. Silencing of cell line HO-1 by specific small interfering RNA (siRNA) was evaluated using real-time quantitative PCR. Cell line viability, apoptosis and intracellular levels of reactive oxygen species (ROS) after transfection were determined using MTT and flow cytometry, respectively. HO-1, Bax, Bcl-2 and A-caspase-3/-9 expression was evaluated using western blot analyses. We found that HO-1 was expressed in 58 of 143 ESCC tumors, mainly in the cytoplasm. There was a significant association between HO-1 expression and tumor grade (P<0.001). Knockdown of HO-1 expression in cell lines was associated with significantly decreased cellular proliferation (P<0.05) and a higher rate of apoptosis (P<0.001) 48 h after treatment. Treatment of the cell lines with the ROS inhibitor N-acetylcys...Continue Reading
References
May 30, 2009·Nature Reviews. Drug Discovery·Dunyaporn TrachoothamPeng Huang
Jan 6, 2011·Oncology Reports·Makito MiyakeYoshihiko Hirao
Sep 14, 2011·Oncotarget·Sally-Anne HeasmanDavid J Macewan
Mar 16, 2012·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·María S DegeseMaría M Facchinetti
Apr 12, 2012·Experimental Biology and Medicine·Yujing YinHong Zhou
Jun 13, 2012·Oncogene·P-H LinL-Y Chau
Oct 25, 2012·Current Pharmaceutical Design·Daniele TibulloFrancesco Di Raimondo
Dec 12, 2012·PloS One·Ismail Ben MosbahPhilippe Compagnon
Dec 22, 2012·Cell Cycle·Rosa Sanchez-AlvarezMichael P Lisanti
Feb 16, 2013·Cell Biology International·Jian-Li HuYi Jin
Nov 5, 2013·Antioxidants & Redox Signaling·Barbara WegielLeo E Otterbein
Nov 5, 2013·BMC Cancer·Sang Jae NohKyu Yun Jang
Nov 10, 2013·Free Radical Biology & Medicine·Hye-Kyung Na, Young-Joon Surh
Jan 1, 2014·Japanese Journal of Clinical Oncology·Sheng-Li YangChao Wu
Mar 13, 2014·The Journal of Nutritional Biochemistry·Shuai WangWei-Qun Ding
Mar 19, 2014·Nature Communications·Emma C JosefssonBenjamin T Kile
May 8, 2014·Journal of Medicinal Chemistry·Wenbing ChenXiaohua Peng
Aug 15, 2014·PloS One·Gi-Shih LienBing-Chang Chen
Sep 23, 2014·International Journal of Cancer. Journal International Du Cancer·Hongmei ZengXue Qin Yu
Mar 10, 2015·Oncotarget·Heather G HambrightRita Ghosh
Mar 11, 2015·Phytotherapy Research : PTR·Bum-Seok OhSung-Hoon Kim
Mar 31, 2015·Biomaterials·Lei JiangZhongwei Gu
Citations
Jul 16, 2014·PloS One·Sashko SpassovAlexander Hoetzel
Jan 8, 2019·The American Journal of Chinese Medicine·En-Yun SuJing-Gung Chung
Oct 6, 2017·Oncotarget·Xia LiWei Chen
Dec 26, 2018·International Journal of Molecular Sciences·Shih-Kai ChiangLing-Chu Chang
Jun 16, 2021·Journal of Cancer Research and Clinical Oncology·M Constanza CamargoKeitaro Matsuo